Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Catherine Shaffer is a contributing writer to BioPharm International, cathshaffer@gmail.com.

Articles

Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.

Cost Considerations Drive Lean Technology in Biomanufacturing

Bosch’s Xelum platform is designed for continuous production of oral solid-dosage forms.

Bosch Introduces Continuous OSD Manufacturing Platform

The program aims to make biosimilars for the treatment of cancer more widely available in middle- and low-income countries.


WHO Launches Biosimilar Pilot Program

EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference.


EMA Promotes Understanding and Use of Biosimilars

Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.

US Prescription Drug Spending to Hit $610 billion in 2021, according to Quintiles/IMS

Matt Bundenthal is direct sales and communications manager at Fette Compacting America, www.fetteamerica.com .

Learn how to prevent common causes of product loss.

Optimizing Yields on Modern Tablet Presses

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Robotic fill/finish systems reduce human intervention, improve flexibility, and allow more gentle handling of containers.

Robots Package Parenteral Products

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.

Catalysis, Flow Chemistry Impact API Manufacturing

Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products.

Manufacturing and Formulation Solutions for Inhaled Dose Forms

Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.